{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:43:51Z","timestamp":1786985031186,"version":"build-2736575974"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["2021\/14609-3"],"award-info":[{"award-number":["2021\/14609-3"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.bbr.2023.114663","type":"journal-article","created":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T11:28:19Z","timestamp":1694431699000},"page":"114663","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Sex and estrous cycle-linked differences in the effect of cannabidiol on panic-like responding in rats and mice"],"prefix":"10.1016","volume":"455","author":[{"given":"Paloma Molina","family":"Hernandes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matheus Fitipaldi","family":"Batistela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jefferson Manoel","family":"Nascimento-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alana Tercino","family":"Frias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melina","family":"Matthiesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alline Cristina","family":"Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thelma Anderson","family":"Lovick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1200-0924","authenticated-orcid":false,"given":"Helio","family":"Zangrossi Jr.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2023.114663_bib1","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1177\/026988119300700112","article-title":"Effects of ipsapirone and cannabidiol on human experimental anxiety","volume":"7","author":"Zuardi","year":"1993","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.bbr.2023.114663_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2018.02009","article-title":"Translational investigation of the therapeutic potential of cannabidiol (CBD): Toward a new age","volume":"9","author":"Crippa","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbr.2023.114663_bib3","first-page":"29","article-title":"Neuropharmacological effects of the main phytocannabinoids: a narrative review","author":"dos Santos","year":"2020","journal-title":"Adv. Exp. Med. Biol. B. Ser. 1264 Cannabinoids Neuropsychiatr. Disord."},{"key":"10.1016\/j.bbr.2023.114663_bib4","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1089\/can.2016.0034","article-title":"An update on safety and side effects of cannabidiol: a review of clinical data and relevant animal studies","volume":"2","author":"Iffland","year":"2017","journal-title":"Cannabis Cannabinoid Res"},{"key":"10.1016\/j.bbr.2023.114663_bib5","article-title":"Current cannabidiol safety: a review","author":"Singh","year":"2022","journal-title":"Curr. Drug Saf."},{"key":"10.1016\/j.bbr.2023.114663_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics14122598","article-title":"Adverse effects of oral cannabidiol: an updated systematic review of randomized controlled trials (2020\u20132022)","volume":"14","author":"Souza","year":"2022","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.bbr.2023.114663_bib7","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s43856-022-00202-8","article-title":"Clinical and cognitive improvement following full-spectrum, high-cannabidiol treatment for anxiety: open-label data from a two-stage, phase 2 clinical trial","volume":"2","author":"Dahlgren","year":"2022","journal-title":"Commun. Med."},{"key":"10.1016\/j.bbr.2023.114663_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/biom10111575","article-title":"Cannabidiol: a potential new alternative for the treatment of anxiety, depression, and psychotic disorders","volume":"10","author":"Garc\u00eda-Guti\u00e9rrez","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.bbr.2023.114663_bib9","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1089\/can.2019.0052","article-title":"Use of cannabidiol for the treatment of anxiety: a short synthesis of pre-clinical and clinical evidence","volume":"5","author":"Wright","year":"2020","journal-title":"Cannabis Cannabinoid Res"},{"key":"10.1016\/j.bbr.2023.114663_bib10","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/npp.2011.6","article-title":"Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-nave social phobia patients","volume":"36","author":"Bergamaschi","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2023.114663_bib11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1590\/1516-4446-2017-0015","article-title":"Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test","volume":"41","author":"Linares","year":"2019","journal-title":"Rev. Bras. Psiquiatr."},{"key":"10.1016\/j.bbr.2023.114663_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2017.00259","article-title":"Inverted U-shaped dose-response curve of the anxiolytic effect of cannabidiol during public speaking in real life","volume":"8","author":"Zuardi","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbr.2023.114663_bib13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00213-012-2878-7","article-title":"Involvement of serotonin-mediated neurotransmission in the dorsal periaqueductal gray matter on cannabidiol chronic effects in panic-like responses in rats","volume":"226","author":"Campos","year":"2013","journal-title":"Psychopharmacol. (Berl. )"},{"key":"10.1016\/j.bbr.2023.114663_bib14","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.neuropharm.2018.03.001","article-title":"The anxiolytic effects of cannabidiol in chronically stressed mice are mediated by the endocannabinoid system: role of neurogenesis and dendritic remodeling","volume":"135","author":"Foga\u00e7a","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2023.114663_bib15","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1098\/rstb.2011.0389","article-title":"Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders","volume":"367","author":"Campos","year":"2012","journal-title":"Philos. Trans. R. Soc. B Biol. Sci."},{"key":"10.1016\/j.bbr.2023.114663_bib16","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.3390\/ijms22041863","article-title":"Insights from preclinical research","volume":"2021","author":"Melas","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbr.2023.114663_bib17","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neubiorev.2016.12.033","article-title":"The endocannabinoid system as a target for novel anxiolytic drugs","volume":"76","author":"Patel","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbr.2023.114663_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108626","article-title":"Endocannabinoids, cannabinoids and the regulation of anxiety","volume":"195","author":"Petrie","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2023.114663_bib19","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.yfrne.2014.05.004","article-title":"Sex differences in anxiety and depression clinical perspectives","volume":"35","author":"Altemus","year":"2014","journal-title":"Front. Neuroendocr."},{"key":"10.1016\/j.bbr.2023.114663_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108684","article-title":"Female but not male rats show biphasic effects of low doses of \u03949-tetrahydrocannabinol on anxiety: can cannabidiol interfere with these effects?","volume":"196","author":"Salviato","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2023.114663_bib21","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1177\/02698811221125440","article-title":"Sex-dependent differences in the anxiolytic-like effect of cannabidiol in the elevated plus-maze","volume":"36","author":"Fabris","year":"2022","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.bbr.2023.114663_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fpsyt.2021.711065","article-title":"Effect of estrous cycle on behavior of females in rodent tests of anxiety","volume":"12","author":"Lovick","year":"2021","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.bbr.2023.114663_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2022.105733","article-title":"Commonly-used rodent tests of anxiety-like behavior lack predictive validity for human sex differences","volume":"141","author":"B\u00f6rchers","year":"2022","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bbr.2023.114663_bib24","first-page":"4","article-title":"Gender differences in the epidemiology and treatment of anxiety disorders","volume":"60","author":"Pigott","year":"1999","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.bbr.2023.114663_bib25","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.jpsychires.2011.03.006","article-title":"Gender differences in anxiety disorders: prevalence, course of illness, comorbidity and burden of illness","volume":"45","author":"McLean","year":"2011","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.bbr.2023.114663_bib26","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/0006-3223(94)00154-U","article-title":"Menstrual cycle-related sensitivity to 35% CO2 in panic patients","volume":"37","author":"Perna","year":"1995","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2023.114663_bib27","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00737-021-01187-4","article-title":"Symptom fluctuation over the menstrual cycle in anxiety disorders, PTSD, and OCD: a systematic review","volume":"25","author":"Green","year":"2022","journal-title":"Arch. Women\u2019s. Ment. Health"},{"key":"10.1016\/j.bbr.2023.114663_bib28","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/HRP.0000000000000329","article-title":"Psychiatric symptoms across the menstrual cycle in adult women: a comprehensive review","volume":"30","author":"Handy","year":"2022","journal-title":"Harv. Rev. Psychiatry"},{"key":"10.1016\/j.bbr.2023.114663_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11920-020-01221-9","article-title":"The impact of the menstrual cycle and underlying hormones in anxiety and PTSD: what do we know and where do we go from here?","volume":"23","author":"Nillni","year":"2021","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.bbr.2023.114663_bib30","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s00737-022-01246-4","article-title":"Premenstrual exacerbation of mental health disorders: a systematic review of prospective studies","volume":"25","author":"Nolan","year":"2022","journal-title":"Arch. Women\u2019s. Ment. Health"},{"key":"10.1016\/j.bbr.2023.114663_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ani10071199","article-title":"Levelling the translational gap for animal to human efficacy data","volume":"10","author":"Ferreira","year":"2020","journal-title":"Animals"},{"key":"10.1016\/j.bbr.2023.114663_bib32","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/s41386-022-01309-1","article-title":"What\u2019s wrong with my experiment?: the impact of hidden variables on neuropsychopharmacology research","volume":"47","author":"Butler-Struben","year":"2022","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2023.114663_bib33","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1037\/0021-843X.108.3.473","article-title":"Exaggerated anxiety is not unique to CO2 in panic disorder: a comparison of hypercapnic and hypoxic challenges","volume":"108","author":"Beck","year":"1999","journal-title":"J. Abnorm. Psychol."},{"key":"10.1016\/j.bbr.2023.114663_bib34","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/da.20048","article-title":"Behavioral and cardiovascular effects of 7.5% CO2 in human volunteers","volume":"21","author":"Bailey","year":"2005","journal-title":"Depress Anxiety"},{"issue":"9","key":"10.1016\/j.bbr.2023.114663_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2016.162","article-title":"CO2 exposure as translational cross-species experimental model for panic","volume":"6","author":"Leibold","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.bbr.2023.114663_bib36","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.neuroscience.2015.08.045","article-title":"Serotonin in the dorsal periaqueductal gray inhibits panic-like defensive behaviors in rats exposed to acute hypoxia","volume":"307","author":"Spiacci","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2023.114663_bib37","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1177\/02698811211058986","article-title":"Enhanced responsiveness to hypoxic panicogenic challenge in female rats in late diestrus is suppressed by short-term, low-dose fluoxetine: Involvement of the dorsal raphe nucleus and the dorsal periaqueductal gray","volume":"35","author":"Batistela","year":"2021","journal-title":"J. Psychopharmacology"},{"key":"10.1016\/j.bbr.2023.114663_bib38","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.pnpbp.2017.10.018","article-title":"Panic-like escape response elicited in mice by exposure to CO(2), but not hypoxia","volume":"81","author":"Spiacci","year":"2018","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2023.114663_bib39","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00737-012-0302-2","article-title":"The role of menstrual cycle phase and anxiety sensitivity in catastrophic misinterpretation of physical symptoms during a CO2 challenge","volume":"15","author":"Nillni","year":"2012","journal-title":"Arch. Women\u2019s. Ment. Health"},{"key":"10.1016\/j.bbr.2023.114663_bib40","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1037\/0022-006X.68.3.425","article-title":"Psychophysiological, somatic, and affective changes across the menstrual cycle in women with panic disorder","volume":"68","author":"Sigmon","year":"2000","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.bbr.2023.114663_bib41","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1210\/endo-94-6-1704","article-title":"Plasma concentration of LH, FSH, prolactin, progesterone and estradiol-17beta throughout the 4-day estrous cycle of the rat","volume":"94","author":"Butcher","year":"1974","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbr.2023.114663_bib42","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s00213-011-2415-0","article-title":"Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), \u0394 9-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behav","volume":"219","author":"Deiana","year":"2012","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2023.114663_bib43","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/BF02244012","article-title":"Antianxiety effect of cannabidiol in the elevated plus-maze","volume":"100","author":"Guimar\u00e3es","year":"1990","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2023.114663_bib44","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1017\/S1461145712001502","article-title":"The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: Involvement of the endocannabinoid system","volume":"16","author":"Campos","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.bbr.2023.114663_bib45","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1476-5381.2009.00521.x","article-title":"Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT 1A receptors","volume":"159","author":"Zanelati","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbr.2023.114663_bib46","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.neuroscience.2006.08.058","article-title":"Neuronal excitability in the periaqueductal grey matter during the estrous cycle in female Wistar rats","volume":"144","author":"Brack","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2023.114663_bib47","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.euroneuro.2014.11.017","article-title":"Elevation of brain allopregnanolone rather than 5-HT release by short term, low dose fluoxetine treatment prevents the estrous cycle-linked increase in stress sensitivity in female rats","volume":"25","author":"Devall","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.bbr.2023.114663_bib48","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1007\/s00424-017-2022-y","article-title":"Influence of estrous cycle hormonal fluctuations and gonadal hormones on the ventilatory response to hypoxia in female rats","volume":"469","author":"Marques","year":"2017","journal-title":"Pflug. Arch. Eur. J. Physiol."},{"key":"10.1016\/j.bbr.2023.114663_bib49","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s11920-022-01376-7","article-title":"What pre-clinical rat models can tell us about anxiety across the menstrual cycle in healthy and clinically anxious humans","volume":"24","author":"Pestana","year":"2022","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.bbr.2023.114663_bib50","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/0306-4522(92)90365-9","article-title":"Changes of rat striatal neuronal membrane morphology and steroid content during the estrous cycle","volume":"49","author":"Morissette","year":"1992","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2023.114663_bib51","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0006-8993(97)00749-X","article-title":"Brain neurosteroids during the mouse oestrous cycle","volume":"766","author":"Corp\u00e9chot","year":"1997","journal-title":"Brain Res"},{"key":"10.1016\/j.bbr.2023.114663_bib52","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00213-008-1168-x","article-title":"Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats","volume":"199","author":"Campos","year":"2008","journal-title":"Psychopharmacol. (Berl. )"},{"key":"10.1016\/j.bbr.2023.114663_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109316","article-title":"Cannabidiol attenuates fear memory expression in female rats via hippocampal 5-HT1A but not CB1 or CB2 receptors","volume":"223","author":"Franzen","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2023.114663_bib54","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0306-3623(94)90027-2","article-title":"Anxiolytic effect of cannabidiol derivatives in the","volume":"25","author":"Guimaraes","year":"1994","journal-title":"Gen. Pharm."},{"key":"10.1016\/j.bbr.2023.114663_bib55","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0022-3565(25)13195-9","article-title":"Pharmacological characterization of cannabinoids in the elevated plus maze","volume":"3","author":"Onaivi","year":"1990","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbr.2023.114663_bib56","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.pbb.2019.05.002","article-title":"Cannabidiol (CBD) reduces anxiety-related behavior in mice via an FMRP-independent mechanism","volume":"181","author":"Zieba","year":"2019","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbr.2023.114663_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/ph15040473","article-title":"Cannabinoid CB1 receptor involvement in the actions of CBD on anxiety and coping behaviors in mice","volume":"15","author":"Austrich-Olivares","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bbr.2023.114663_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2022.173498","article-title":"Single cannabidiol administration affects anxiety-, obsessive compulsive-, object memory-, and attention-like behaviors in mice in a sex and concentration dependent manner","volume":"222","author":"Huffstetler","year":"2023","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbr.2023.114663_bib59","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.pnpbp.2015.06.017","article-title":"Influence of single and repeated cannabidiol administration on emotional behavior and markers of cell proliferation and neurogenesis in non-stressed mice","volume":"64","author":"Schiavon","year":"2016","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2023.114663_bib60","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/FBP.0000000000000636","article-title":"Effects of cannabidiol and \u03949-tetrahydrocannabinol in the elevated plus maze in mice","volume":"3","author":"Liu","year":"2022","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.bbr.2023.114663_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnbeh.2019.00032","article-title":"Acute cannabinoids produce robust anxiety-like and locomotor effects in mice, but long-term consequences are age- and sex-dependent","volume":"13","author":"Kasten","year":"2019","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.bbr.2023.114663_bib62","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1007\/s11011-022-01071-9","article-title":"Cannabidiol ameliorates the anxiogenic and compulsive-like behaviors induced by chronic consumption of a high-carbohydrate diet in male mice","volume":"37","author":"Mar\u00e7al","year":"2022","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.bbr.2023.114663_bib63","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1007\/s00213-017-4626-5","article-title":"Effect of prior foot shock stress and \u03949-tetrahydrocannabinol, cannabidiolic acid, and cannabidiol on anxiety-like responding in the light-dark emergence test in rats","volume":"234","author":"Rock","year":"2017","journal-title":"Psychopharmacol. (Berl. )"},{"key":"10.1016\/j.bbr.2023.114663_bib64","doi-asserted-by":"crossref","DOI":"10.1177\/0269881119841833","article-title":"Short-term, low-dose fluoxetine prevents oestrous cycle-linked increase in anxiety-like behaviour in female rats","author":"Machado Figueiredo","year":"2019","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.bbr.2023.114663_bib65","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.bcp.2018.08.046","article-title":"Cannabidiol skews biased agonism at cannabinoid CB1 and CB2 receptors with smaller effect in CB1-CB2 heteroreceptor complexes","volume":"157","author":"Navarro","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbr.2023.114663_bib66","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1111\/bph.13250","article-title":"Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor","volume":"172","author":"Laprairie","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbr.2023.114663_bib67","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s13311-015-0377-3","article-title":"Molecular targets of cannabidiol in neurological disorders","volume":"12","author":"Ibeas Bih","year":"2015","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.bbr.2023.114663_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/prp2.682","article-title":"Diversity of molecular targets and signaling pathways for CBD","volume":"8","author":"de Almeida","year":"2020","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.bbr.2023.114663_bib69","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/molecules25215186","article-title":"Molecular targets of cannabidiol in experimental models of neurological disease","volume":"25","author":"Silvestro","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bbr.2023.114663_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2020.618065","article-title":"Glial cells and their contribution to the mechanisms of action of cannabidiol in neuropsychiatric disorders","volume":"11","author":"Scarante","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbr.2023.114663_bib71","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.bbr.2015.02.023","article-title":"Effects of intra-infralimbic prefrontal cortex injections of cannabidiol in the modulation of emotional behaviors in rats: Contribution of 5HT1A receptors and stressful experiences","volume":"286","author":"Marinho","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2023.114663_bib72","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.bbr.2010.05.004","article-title":"Intra-dorsal periaqueductal gray administration of cannabidiol blocks panic-like response by activating 5-HT1A receptors","volume":"213","author":"Soares","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2023.114663_bib73","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1177\/0269881113493363","article-title":"The role of 5-HT1A receptors in the anti-aversive effects of cannabidiol on panic attack-like behaviors evoked in the presence of the wild snake Epicrates cenchria crassus (Reptilia, Boidae)","volume":"27","author":"Twardowschy","year":"2013","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.bbr.2023.114663_bib74","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.phrs.2017.02.022","article-title":"The direct actions of cannabidiol and 2-arachidonoyl glycerol at GABAA receptors","volume":"119","author":"Bakas","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbr.2023.114663_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/prp2.950","article-title":"Impact of the mouse estrus cycle on cannabinoid receptor agonist-induced molecular and behavioral outcomes","volume":"10","author":"Kim","year":"2022","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.bbr.2023.114663_bib76","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/ddr.21461","article-title":"Dose translation between laboratory animals and human in preclinical and clinical phases of drug development","volume":"79","author":"Nair","year":"2018","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.bbr.2023.114663_bib77","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.euroneuro.2023.04.001","article-title":"Anxiolytic effects of endocannabinoid enhancing compounds: a systematic review and meta-analysis","volume":"72","author":"Kwee","year":"2023","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.bbr.2023.114663_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.psycom.2022.100074","article-title":"Systematic literature review of human studies assessing the efficacy of cannabidiol for social anxiety","volume":"2","author":"Fliegel","year":"2022","journal-title":"Psychiatry Res. Commun."},{"key":"10.1016\/j.bbr.2023.114663_bib79","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/j.1552-4604.2002.tb05998.x","article-title":"Cannabidiol: an overview of some pharmacological aspects","volume":"42","author":"Mechoulam","year":"2002","journal-title":"J. Clin. Pharmacol."}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432823003819?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432823003819?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T13:41:37Z","timestamp":1759066897000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432823003819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":79,"alternative-id":["S0166432823003819"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2023.114663","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sex and estrous cycle-linked differences in the effect of cannabidiol on panic-like responding in rats and mice","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2023.114663","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114663"}}